The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
In silico ADME/T modelling for rational drug design
Open accessAbstract
In recent decades, in silico absorption, distribution, metabolism, excretion (ADME), and toxicity (T) modelling as a tool for rational drug design has received considerable attention from pharmaceutical scientists, and various ADME/T-related prediction models have been reported. The high-throughput and low-cost nature of these models permits a more streamlined drug development process in which the identification of hits or their structural optimization can be guided based on a parallel investigation of bioavailability and safety, along with activity. However, the effectiveness of these tools is highly dependent on their capacity to cope with needs at different stages, e.g. their use in candidate selection has been limited due to their lack of the required predictability. For some events or endpoints involving more complex mechanisms, the current in silico approaches still need further improvement. In this review, we will briefly introduce the development of in silico models for some physicochemical parameters, ADME properties and toxicity evaluation, with an emphasis on the modelling approaches thereof, their application in drug discovery, and the potential merits or deficiencies of these models. Finally, the outlook for future ADME/T modelling based on big data analysis and systems sciences will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Quantum Mechanical Continuum Solvation Models
Tomasi, J., Mennucci, B., & Cammi, R. (2005) · Chemical Reviews · doi:10.1021/cr9904009 · Cited by 16,868
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Ames, B. N., McCann, J., & Yamasaki, E. (1975) · Mutation Research/Environmental Mutagenesis and Related Subjects · doi:10.1016/0165-1161(75)90046-1 · Cited by 7,381
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Semianalytical treatment of solvation for molecular mechanics and dynamics
Still, W. C., Tempczyk, A., Hawley, R. C., & Hendrickson, T. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00172a038 · Cited by 3,643
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Data-intensive applications, challenges, techniques and technologies: A survey on Big Data
Philip Chen, C. L., & Zhang, C.-Y. (2014) · Information Sciences · doi:10.1016/j.ins.2014.01.015 · Cited by 3,047
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Implicit Solvation Models: Equilibria, Structure, Spectra, and Dynamics
Cramer, C. J., & Truhlar, D. G. (1999) · Chemical Reviews · doi:10.1021/cr960149m · Cited by 2,308
The Effect of Structure upon the Reactions of Organic Compounds. Benzene Derivatives
Hammett, L. P. (1937) · Journal of the American Chemical Society · doi:10.1021/ja01280a022 · Cited by 2,249
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects
Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050540c · Cited by 2,031
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
A physiological approach to hepatic drug clearance
Wilkinson, G. R., & Shand, D. G. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975184377 · Cited by 1,873
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
The Many Roles of Computation in Drug Discovery
Jorgensen, W. L. (2004) · Science · doi:10.1126/science.1096361 · Cited by 1,554
Current Status of the AMOEBA Polarizable Force Field
Ponder, J. W., Wu, C., Ren, P., Pande, V. S., Chodera, J. D., Schnieders, M. J., Haque, I., Mobley, D. L., Lambrecht, D. S., DiStasio, R. A., et al. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp910674d · Cited by 1,440
Molecular dynamics simulations and drug discovery
Durrant, J. D., & McCammon, J. A. (2011) · BMC Biology · doi:10.1186/1741-7007-9-71 · Cited by 1,403
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Prediction of drug solubility from structure
Jorgensen, W. L., & Duffy, E. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00008-x · Cited by 891
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
The influence of lipophilicity in drug discovery and design
Arnott, J. A., & Planey, S. L. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.714363 · Cited by 868
Some Relations between Reaction Rates and Equilibrium Constants.
Hammett, L. P. (1935) · Chemical Reviews · doi:10.1021/cr60056a010 · Cited by 866
Pang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059688 · Cited by 797 · cited 1×
“Compared with the well-stirred model, the parallel tube model assumes that the liver is a series of parallel tubes and that there is a declining hepatic drug concentration along the length of the tube (Pang & Rowland, 1977).”
Screening Methods in Pharmacology
(1971) · Elsevier eBooks · doi:10.1016/c2013-0-11630-3 · Cited by 786
ProTox: a web server for the in silico prediction of rodent oral toxicity
Drwal, M. N., Banerjee, P., Dunkel, M., Wettig, M. R., & Preissner, R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku401 · Cited by 738
Derivation and Validation of Toxicophores for Mutagenicity Prediction
Kazius, J., McGuire, R., & Bursi, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040835a · Cited by 666
Toxicology for the twenty-first century
Hartung, T. (2009) · Nature · doi:10.1038/460208a · Cited by 661
Mannhold, R., Poda, G. I., Ostermann, C., & Tetko, I. V. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21494 · Cited by 654
Predicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Computational solutions to large‐scale data management and analysis
Schadt, E. E., Linderman, M. D., Sorenson, J., Lee, L., & Nolan, G. P. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2857 · Cited by 631
Systems biology in drug discovery
Butcher, E. C., Berg, E. L., & Kunkel, E. J. (2004) · Nature Biotechnology · doi:10.1038/nbt1017 · Cited by 605
The Poisson–Boltzmann equation for biomolecular electrostatics: a tool for structural biology
Fogolari, F., Brigo, A., & Molinari, H. (2002) · Journal of Molecular Recognition · doi:10.1002/jmr.577 · Cited by 587
Computational methods for the prediction of ‘drug-likeness’
Clark, D. E., & Pickett, S. D. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01451-8 · Cited by 578
When poor solubility becomes an issue: From early stage to proof of concept
Stegemann, S., Leveiller, F., Franchi, D., de Jong, H., & Lindén, H. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.110 · Cited by 567
Lusci, A., Pollastri, G., & Baldi, P. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400187y · Cited by 555
Zhao, P., Zhang, L., Grillo, J. A., Liu, Q., Bullock, J. M., Moon, Y. J., Song, P., Brar, S. S., Madabushi, R., Wu, T. C., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.298 · Cited by 522
Probing the links between in vitro potency, ADMET and physicochemical parameters
Gleeson, M. P., Hersey, A., Montanari, D., & Overington, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3367 · Cited by 503
The Comparative Toxicogenomics Database: update 2013
Davis, A. P., Murphy, C. G., Johnson, R., Lay, J. M., Lennon-Hopkins, K., Saraceni-Richards, C., Sciaky, D., King, B. L., Rosenstein, M. C., Wiegers, T. C., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks994 · Cited by 497
In silico prediction of blood–brain barrier permeation
Clark, D. E. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02827-7 · Cited by 483
Drug discovery in pharmaceutical industry: productivity challenges and trends
Khanna, I. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.007 · Cited by 479 · cited 1×
“Current pharmaceutical research and development (R&D) is a high-risk investment that is characterized by a high cost and increasing attrition rate at late-stage drug development (Khanna, 2012).”
BackgroundA universal approach for continuum solvent pK a calculations: are we there yet?
Ho, J., & Coote, M. L. (2010) · Theoretical Chemistry Accounts · doi:10.1007/s00214-009-0667-0 · Cited by 464
A compartmental absorption and transit model for estimating oral drug absorption
Yu, L. X., & Amidon, G. L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00147-7 · Cited by 455
Screening Methods in Pharmacology
(1965) · Elsevier eBooks · doi:10.1016/c2013-0-12513-5 · Cited by 453
Toxicogenomics and systems toxicology: aims and prospects
Waters, M. D., & Fostel, J. M. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1493 · Cited by 415
Process data analytics in the era of big data
Qin, S. J. (2014) · AIChE Journal · doi:10.1002/aic.14523 · Cited by 383
Estimation of the aqueous solubility I: Application to organic nonelectrolytes
Jain, N., & Yalkowsky, S. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200102)90:2<234::aid-jps14>3.0.co;2-v · Cited by 375
Computer Prediction of Possible Toxic Action from Chemical Structure; The DEREK System
Sanderson, D. M., & Earnshaw, C. G. (1991) · Human & Experimental Toxicology · doi:10.1177/096032719101000405 · Cited by 368
Systems Toxicology: From Basic Research to Risk Assessment
Sturla, S. J., Boobis, A. R., FitzGerald, R. E., Hoeng, J., Kavlock, R. J., Schirmer, K., Whelan, M., Wilks, M. F., & Peitsch, M. C. (2014) · Chemical Research in Toxicology · doi:10.1021/tx400410s · Cited by 366
Ou-Yang, S.-S., Lu, J.-Y., Kong, X.-Q., Liang, Z.-J., Luo, C., & Jiang, H. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.109 · Cited by 352
Self-citationEstimation of ADME Properties with Substructure Pattern Recognition
Shen, J., Cheng, F., Xu, Y., Li, W., & Tang, Y. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100104j · Cited by 349
Self-citationThe importance of plasma protein binding in drug discovery
Trainor, G. L. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.1.51 · Cited by 348
Unveiling the role of network and systems biology in drug discovery
Pujol, A., Mosca, R., Farrés, J., & Aloy, P. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.006 · Cited by 346
A Bayesian Approach to in Silico Blood-Brain Barrier Penetration Modeling
Martins, I. F., Teixeira, A. L., Pinheiro, L., & Falcao, A. O. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300124c · Cited by 331
The significance of acid/base properties in drug discovery
Manallack, D. T., Prankerd, R. J., Yuriev, E., Oprea, T. I., & Chalmers, D. K. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35348b · Cited by 329
SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism
Rydberg, P., Gloriam, D. E., Zaretzki, J., Breneman, C., & Olsen, L. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100016x · Cited by 327
MULTICASE 1. A Hierarchical Computer Automated Structure Evaluation Program
Klopman, G. (1992) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19920110208 · Cited by 313
Random walk in orthogonal space to achieve efficient free-energy simulation of complex systems
Zheng, L., Chen, M., & Yang, W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810631106 · Cited by 310
Carpenter, T. S., Kirshner, D. A., Lau, E. Y., Wong, S. E., Nilmeier, J. P., & Lightstone, F. C. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.06.024 · Cited by 306
Toward in silico structure-based ADMET prediction in drug discovery
Moroy, G., Martiny, V. Y., Vayer, P., Villoutreix, B. O., & Miteva, M. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.023 · Cited by 302
Ali, J., Camilleri, P., Brown, M. B., Hutt, A. J., & Kirton, S. B. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200387c · Cited by 300
Structure-based drug design to augment hit discovery
Kalyaanamoorthy, S., & Chen, Y.-P. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.07.006 · Cited by 296
In Silico ADMET Prediction: Recent Advances, Current Challenges and Future Trends
Cheng, F., Li, W., Liu, G., & Tang, Y. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990033 · Cited by 295
Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms
Kirchmair, J., Williamson, M. J., Tyzack, J. D., Tan, L., Bond, P. J., Bender, A., & Glen, R. C. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200542m · Cited by 289
Quantitative Structure−Activity Relationship Modeling of Rat Acute Toxicity by Oral Exposure
Zhu, H., Martin, T. M., Ye, L., Sedykh, A., Young, D. M., & Tropsha, A. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900189p · Cited by 287
Making Things Work: Solving Complex Problems in a Complex World
Bar-Yam, Y. (2004) · CERN Document Server (European Organization for Nuclear Research) · Cited by 284
Kovalenko, A., & Hirata, F. (2000) · The Journal of Chemical Physics · doi:10.1063/1.481676 · Cited by 283
Predictive in silico modeling for hERG channel blockers
Aronov, A. M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03278-7 · Cited by 267
In silico Prediction of Chemical Ames Mutagenicity
Xu, C., Cheng, F., Chen, L., Du, Z., Li, W., Liu, G., Lee, P. W., & Tang, Y. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300400a · Cited by 266
Sushko, I., Salmina, E., Potemkin, V. A., Poda, G., & Tetko, I. V. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300245q · Cited by 263
Bicker, J., Alves, G., Fortuna, A., & Falcão, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.012 · Cited by 262
Cheminformatic Models To Predict Binding Affinities to Human Serum Albumin
Colmenarejo, G., Alvarez-Pedraglio, A., & Lavandera, J.-L. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010960b · Cited by 254
Prediction of the strengths of organic acids
BARLIN, G. B., & PERRIN, D. D. (1966) · Quarterly Reviews Chemical Society · doi:10.1039/qr9662000075 · Cited by 240
Computational toxicology in drug development
Muster, W., Breidenbach, A., Fischer, H., Kirchner, S., Müller, L., & Pähler, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.007 · Cited by 215
Zhao, P., Rowland, M., & Huang, S.-M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.68 · Cited by 212
Acidic and Basic Drugs in Medicinal Chemistry: A Perspective
Charifson, P. S., & Walters, W. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501000a · Cited by 208
The utility of modeling and simulation in drug development and regulatory review
Huang, S.-M., Abernethy, D. R., Wang, Y., Zhao, P., & Zineh, I. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23570 · Cited by 206
Self-citationLlinàs, A., Glen, R. C., & Goodman, J. M. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800058v · Cited by 204
Pick, A., Müller, H., Mayer, R., Haenisch, B., Pajeva, I. K., Weigt, M., Bönisch, H., Müller, C. E., & Wiese, M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.043 · Cited by 192
Ekins, S., Kim, R. B., Leake, B. F., Dantzig, A. H., Schuetz, E. G., Lan, L.-B., Yasuda, K., Shepard, R. L., Winter, M. A., Schuetz, J. D., et al. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12192-x · Cited by 191
Whole-body physiologically based pharmacokinetic models
Nestorov, I. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.2.235 · Cited by 188
The Japanese toxicogenomics project: Application of toxicogenomics
Uehara, T., Ono, A., Maruyama, T., Kato, I., Yamada, H., Ohno, Y., & Urushidani, T. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900169 · Cited by 187
In Silico Prediction of Chemical Acute Oral Toxicity Using Multi-Classification Methods
Li, X., Chen, L., Cheng, F., Wu, Z., Bian, H., Xu, C., Li, W., Liu, G., Shen, X., & Tang, Y. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5000467 · Cited by 181
SyGMa: Combining Expert Knowledge and Empirical Scoring in the Prediction of Metabolites
Ridder, L., & Wagener, M. (2008) · ChemMedChem · doi:10.1002/cmdc.200700312 · Cited by 181
Mechanistic Approaches to Predicting Oral Drug Absorption
Huang, W., Lee, S. L., & Yu, L. X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9098-z · Cited by 181
Wang, S., Li, Y., Wang, J., Chen, L., Zhang, L., Yu, H., & Hou, T. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300023x · Cited by 180
Comparison of Nine Programs Predicting p Ka Values of Pharmaceutical Substances
Liao, C., & Nicklaus, M. C. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900289x · Cited by 179
A Computational Ensemble Pharmacophore Model for Identifying Substrates of P-Glycoprotein
Penzotti, J. E., Lamb, M. L., Evensen, E., & Grootenhuis, P. D. J. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255062 · Cited by 177
Textbook of Drug Design and Discovery
(2016) · CRC Press eBooks · doi:10.1201/9781315371818 · Cited by 175
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Edginton, A. N., Theil, F., Schmitt, W., & Willmann, S. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.9.1143 · Cited by 173
Kido, Y., Matsson, P., & Giacomini, K. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2001629 · Cited by 169
Recent Advances in Computational Prediction of Drug Absorption and Permeability in Drug Discovery
Hou, T., Wang, J., Zhang, W., et al. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778201558 · Cited by 169
META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals
Klopman, G., Dimayuga, M., & Talafous, J. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00022a014 · Cited by 169
Kell, D. B., & Goodacre, R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.014 · Cited by 169
Physicochemical drug properties associated within vivotoxicological outcomes: a review
Price, D. A., Blagg, J., Jones, L. H., Greene, N., & Wager, T. T. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903042318 · Cited by 167
Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein
Ekins, S., Kim, R. B., Leake, B. F., Dantzig, A. H., Schuetz, E. G., Lan, L.-B., Yasuda, K., Shepard, R. L., Winter, M. A., Schuetz, J. D., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.964 · Cited by 166
The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies
Mattingly, C. J., Rosenstein, M. C., Colby, G. T., Forrest Jr, J. N., & Boyer, J. L. (2006) · Journal of Experimental Zoology Part A: Comparative Experimental Biology · doi:10.1002/jez.a.307 · Cited by 161
Wittwer, M., Zur, A. A., Khuri, N., Kido, Y., Kosaka, A. H., Zhang, X., Morrissey, K. M., Šali, A., Huang, Y., & Giacomini, K. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301302s · Cited by 158
Prodrugs : challenges and rewards
Stella, V. J. (2007) · Cited by 153
Contributions of Molecular Properties to Drug Promiscuity
Tarcsay, Á., & Keserű, G. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301514n · Cited by 153
Zsila, F., Bikádi, Z., Malik, D., Hári, P., Pechan, I., Bérces, A., & Hazai, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr284 · Cited by 152
The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review
Huang, S.-M., & Rowland, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.320 · Cited by 150
Data-driven medicinal chemistry in the era of big data
Lusher, S. J., McGuire, R., van Schaik, R. C., Nicholson, C. D., & de Vlieg, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.004 · Cited by 150
Palmer, D. S., Frolov, A. I., Ratkova, E. L., & Fedorov, M. V. (2010) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/22/49/492101 · Cited by 146
Considering the impact drug-like properties have on the chance of success
Yusof, I., & Segall, M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.02.008 · Cited by 137
In Silico Prediction of Blood Brain Barrier Permeability: An Artificial Neural Network Model
Garg, P., & Verma, J. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050303i · Cited by 134
Stella, V. J., Tilley, J., Oliyai, R., Maag, H., Hageman, M. J., & Borchardt, R. T. (2007) · Springer eBooks · doi:10.1007/978-0-387-49785-3 · Cited by 131
Benfenati, E., Benigni, R., DeMarini, D. M., Helma, C., Kirkland, D., Martin, T. M., Mazzatorta, P., Ouédraogo, G., RICHARD, A. M., Schilter, B., et al. (2009) · Journal of Environmental Science and Health Part C · doi:10.1080/10590500902885593 · Cited by 129
Garrido, N. M. D. F., Queimada, A. J., Jorge, M., Macedo, E. A., & Economou, I. G. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct900214y · Cited by 128
Computational Models for Identifying Potential P-Glycoprotein Substrates and Inhibitors
Crivori, P., Reinach, B., Pezzetta, D., & Poggesi, I. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050071a · Cited by 128
Zolk, O., Solbach, T. F., König, J., & Fromm, M. F. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0369-5 · Cited by 127
Voronkov, A. E., Holsworth, D. D., Waaler, J., Wilson, S. R., Ekblad, B., Perdreau‐Dahl, H., Dinh, H., Drewes, G., Hopf, C., Morth, J. P., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4000566 · Cited by 121
Site of metabolism prediction for six biotransformations mediated by cytochromes P450
Zheng, M., Luo, X., Shen, Q., Wang, Y., Du, Y., Zhu, W., & Jiang, H. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp140 · Cited by 119
Self-citationComputer-Aided Drug Design: Lead Discovery and Optimization
Xiang, M., Cao, Y., Fan, W., Chen, L., & Mo, Y. (2012) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620712799361825 · Cited by 118
Mullard, A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4239 · Cited by 116
Predicting P-glycoprotein substrates by a quantitative structure–activity relationship model
Gombar, V. K., Polli, J. W., Humphreys, J. E., Wring, S. A., & Serabjit‐Singh, C. J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20035 · Cited by 112
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed
Aarons, L. J. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02560.x · Cited by 110
The log P Parameter as a Molecular Descriptor in the Computer-aided Drug Design – an Overview
Kujawski, J., Popielarska, H., Myka, A., Drabińska, B., & Bernard, M. K. (2012) · Computational Methods in Science and Technology · doi:10.12921/cmst.2012.18.02.81-88 · Cited by 109
Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?
Vicini, P., & van der Graaf, P. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.40 · Cited by 108
Reaction Site Mapping of Xenobiotic Biotransformations
Boyer, S. K., Arnby, C. H., Carlsson, L., Smith, J., Stein, V., & Glen, R. C. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600376q · Cited by 106
Computational methods for drug design and discovery: focus on China
Zheng, M., Liu, X., Xu, Y., Li, H., Luo, C., & Jiang, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.004 · Cited by 105
Self-citationFirst-Principles Calculation of the Intrinsic Aqueous Solubility of Crystalline Druglike Molecules
Palmer, D. S., McDonagh, J. L., Mitchell, J. B. O., van Mourik, T., & Fedorov, M. V. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300345m · Cited by 103
CYP2C9 Structure−Metabolism Relationships: Optimizing the Metabolic Stability of COX-2 Inhibitors
Ahlström, M. M., Ridderström, M., Zamora, I., & Luthman, K. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0705096 · Cited by 101
META. 2. A Dictionary Model of Mammalian Xenobiotic Metabolism
Talafous, J., Sayre, L. M., Mieyal, J. J., & Klopman, G. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00022a015 · Cited by 99
Zhao, P., Vieira, M. D. L. T., Grillo, J. A., Song, P., Wu, T., Zheng, J., Arya, V., Berglund, E. G., Atkinson, A. J., Sugiyama, Y., et al. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011415528 · Cited by 98
Lean Big Data integration in systems biology and systems pharmacology
Ma’ayan, A., Rouillard, A. D., Clark, N. R., Wang, Z., Duan, Q., & Kou, Y. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.07.001 · Cited by 97
Schnieders, M. J., Baltrušaitis, J., Shi, Y., Chattree, G., Zheng, L., Yang, W. Y., & Ren, P. Y. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300035u · Cited by 94
Contrera, J. F., Matthews, E. J., & Benz, R. D. (2003) · Regulatory Toxicology and Pharmacology · doi:10.1016/s0273-2300(03)00071-0 · Cited by 93
High-throughput pKascreening and prediction amenable for ADME profiling
Wan, H., & Ulander, J. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.1.139 · Cited by 86
A QSAR Model of hERG Binding Using a Large, Diverse, and Internally Consistent Training Set
Seierstad, M. J., & Agrafiotis, D. K. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00379.x · Cited by 83
IDSite: An Accurate Approach to Predict P450-Mediated Drug Metabolism
Li, J., Schneebeli, S. T., Bylund, J. H., Farid, R., & Friesner, R. A. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct200462q · Cited by 82
Theoretical Predictions of Drug Absorption in Drug Discovery and Development
Stenberg, P., m, C. A. S. B., Luthman, K., & Artursson, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00005 · Cited by 81
Systems Biology Brings New Dimensions for Structure-Based Drug Design
Pei, J., Yin, N., Ma, X., & Lai, L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504810z · Cited by 81
Fast Approaches for Molecular Polarizability Calculations
Wang, J., Xie, X., Hou, T., & Xu, X. (2007) · The Journal of Physical Chemistry A · doi:10.1021/jp068423w · Cited by 80
The acid–base profile of a contemporary set of drugs: implications for drug discovery
Manallack, D. T. (2009) · SAR and QSAR in environmental research · doi:10.1080/10629360903438313 · Cited by 76
Tan, J., Cong, X. J., Hu, L., Wang, C. X., Jia, L., & Liang, X. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.004 · Cited by 75
Kirchmair, J., Williamson, M. J., Afzal, A. M., Tyzack, J. D., Choy, A. P. K., Howlett, A., Rydberg, P., & Glen, R. C. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400503s · Cited by 74
Using Absolute and Relative Reasoning in the Prediction of the Potential Metabolism of Xenobiotics
Button, W. G., Judson, P. N., Long, A., & Vessey, J. D. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0202739 · Cited by 73
Recent Developments in Computational Prediction of hERG Blockage
Wang, S., Li, Y., Xu, L., et al. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990036 · Cited by 72
Wang, J., Hou, T., & Xu, X. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800406y · Cited by 71
Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm
Huang, J., Ma, G., Ishtiaq, M., & Cheng, Y. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700083n · Cited by 69
QSAR Analysis of Blood–Brain Distribution: The Influence of Plasma and Brain Tissue Binding
Lanevskij, K., Dapkūnas, J., Juška, L., Japertas, P., & Didžiapetris, R. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22442 · Cited by 68
Novel Bayesian classification models for predicting compounds blocking hERG potassium channels
Liu, L., Lu, J., Lu, Y., Zheng, M.-Y., Luo, X., Zhu, W., Jiang, H., & Chen, K. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.35 · Cited by 68
Self-citationThomas, S., Brightman, F. A., Gill, H., Lee, S., & Pufong, B. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21305 · Cited by 66
Predicting the pKa of Small Molecules
Rupp, M., Körner, R., & Tetko, I. V. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795508403 · Cited by 66
New Uses for Old Drugs: Pharmacophore‐Based Screening for the Discovery of P‐Glycoprotein Inhibitors
Palmeira, A., Rodrigues, F., Sousa, E., Pinto, M. M. M., Vasconcelos, M. H., & Fernandes, M. X. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01089.x · Cited by 64
A topological substructural approach for the prediction of P-glycoprotein substrates
Cabrera‐Pérez, M. Á., González‐Álvarez, I., Fernández, C., Navarro, C., & Bermejo, M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20449 · Cited by 64
META. 3. A Genetic Algorithm for Metabolic Transform Priorities Optimization
Klopman, G., Tu, M., & Talafous, J. (1997) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9601123 · Cited by 62
Guo, J.-X., Wu, J. J.-Q., Wright, J. B., & Lushington, G. H. (2006) · Chemical Research in Toxicology · doi:10.1021/tx050090r · Cited by 56
Simple Quantum Chemical Parameters as an Alternative to the Hammett Sigma Constants in QSAR Studies
Ertl, P. (1997) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19970160505 · Cited by 56
Metabolism Site Prediction Based on Xenobiotic Structural Formulas and PASS Prediction Algorithm
Rudik, A. V., Dmitriev, A. V., Lagunin, A. A., Filimonov, D. A., & Poroikov, V. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400472j · Cited by 55
Kienhuis, A. S., Bessems, J. G. M., Pennings, J. L. A., Driessen, M., Luijten, M., van Delft, J. H. M., Peijnenburg, A., & van der Ven, L. T. M. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.10.013 · Cited by 50
Eldred, D. V., & Jurs, P. C. (1999) · SAR and QSAR in environmental research · doi:10.1080/10629369908039170 · Cited by 49
Prieto, P., Kinsner‐Ovaskainen, A., Stanzel, S. F., Albella, B., Artursson, P., Campillo, N. E., Cecchelli, R., Cerrato, L., Díaz, L., Consiglio, E. D., et al. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.07.013 · Cited by 48
Estimation of acute oral toxicity in rat using local lazy learning
Lu, J., Peng, J., Wang, J., Shen, Q., Bi, Y., Gong, L., Zheng, M., Luo, X., Zhu, W., Jiang, H., et al. (2014) · Journal of Cheminformatics · doi:10.1186/1758-2946-6-26 · Cited by 42
Artificial neural network models for prediction of intestinal permeability of oligopeptides
Jung, E., Kim, J., Kim, M., Jung, D. H., Rhee, H., Shin, J., Choi, K., Kang, S., Kim, M.-K., Yun, C., et al. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-245 · Cited by 42
Molecular Similarity and Xenobiotic Metabolism
Adams, S. (2010) · Apollo (University of Cambridge) · doi:10.17863/cam.16274 · Cited by 41
In silico site of metabolism prediction for human UGT-catalyzed reactions
Peng, J., Lu, J., Shen, Q., Zheng, M., Luo, X., Zhu, W., Jiang, H., & Chen, K. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt681 · Cited by 39
Self-citationDrug design strategies : quantitative approaches
Livingstone, D. J., & Davis, A. M. (2012) · Cited by 37
Zhong, L., Ma, C.-Y., Zhang, H., Yang, L., Wan, H.-L., Xie, Q., Li, L., & Yang, S. (2011) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2011.08.009 · Cited by 37
Sorich, M. J., McKinnon, R. A., Miners, J. O., & Smith, P. A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600248e · Cited by 37
Improving the prediction of drug disposition in the brain
Lanevskij, K., Japertas, P., & Didžiapetris, R. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.754423 · Cited by 35
Estimation of Acid Dissociation Constants Using Graph Kernels
Rupp, M., Körner, R., & Tetko, I. V. (2010) · Molecular Informatics · doi:10.1002/minf.201000072 · Cited by 33
Reenu, R., & Vikas, V. (2014) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2013.11.020 · Cited by 33
Accurate In Silico log P Predictions: One Can't Embrace the Unembraceable
Tetko, I. V., Poda, G. I., Ostermann, C., et al. (2009) · QSAR & Combinatorial Science · doi:10.1002/qsar.200960003 · Cited by 32
Tyzack, J. D., Mussa, H. Y., Williamson, M. J., Kirchmair, J., & Glen, R. C. (2014) · Journal of Cheminformatics · doi:10.1186/1758-2946-6-29 · Cited by 31
Pre-processing Feature Selection for Improved C&RT Models for Oral Absorption
Newby, D., Freitas, A. A., & Ghafourian, T. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400378j · Cited by 29
Xu, Y., Liu, X., Li, S., Zhou, N., Gong, L., Luo, C., Luo, X., Zheng, M., Jiang, H., & Chen, K. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400423g · Cited by 26
Self-citationA Predictive Model for Estimating Rat Oral LD 50 Values
Enslein, K., Lander, T. R., Tomb, M. E., & Craig, P. N. (1989) · Toxicology and Industrial Health · doi:10.1177/074823378900500210 · Cited by 23
(1999) · The IMA volumes in mathematics and its applications · doi:10.1007/978-1-4612-1480-9 · Cited by 23
Gleeson, M. P., & Montanari, D. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.711317 · Cited by 22
Applicability of Computational Systems Biology in Toxicology
Kongsbak, K., Hadrup, N., Audouze, K., & Vinggaard, A. M. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12216 · Cited by 16
Toxicogenomics in Biomarker Discovery
DeCristofaro, M. F., & Daniels, K. K. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-048-9_9 · Cited by 13
Maximizing the outcome of early ADMET models: strategies to win the drug-hunting battles?
Wang, J., & Collis, A. J. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.562199 · Cited by 9
Random walk in orthogonal space to achieve efficient free-energy simulation of complex systems
Zhenga, L. (2016) · Cited by 9
A Predictive Model for Estimating Rat Oral Ld 50 Values
Enslein, K., Lander, T. R., Tomb, M. E., & Craig, P. N. (1989) · Toxicology and Industrial Health · doi:10.1177/074823378900500212 · Cited by 9
Essential Concepts in Toxicogenomics
Mendrick, D. L. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-048-9 · Cited by 7
Chapter 2. Drug-Like Physicochemical Properties
Leeson, P. D., & Oprea, T. I. (2011) · RSC drug discovery/RSC drug discovery series · doi:10.1039/9781849733410-00035 · Cited by 4
Cited by
ProTox-II: a webserver for the prediction of toxicity of chemicals
Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky318 · Cited by 3,195
admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties
Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., Liu, G., & Tang, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty707 · Cited by 1,423
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Self-citationDong, J., Wang, N.-N., Yao, Z.-J., Zhang, L., Cheng, Y., Ouyang, D., Lu, A.-P., & Cao, D.-S. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0283-x · Cited by 889
Computational Approaches in Preclinical Studies on Drug Discovery and Development
Wu, F., Zhou, Y., Li, L., Shen, X., Chen, G., Wang, X., Liang, X., Tan, M., & Huang, Z. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00726 · Cited by 446
Metadata
- Authors
- Wang, Y., Xing, J., Xu, Y., Zhou, N., Peng, J., Xiong, Z., Liu, X., Luo, X., Luo, C., Chen, K., Zheng, M., & Jiang, H.
- Venue
- Quarterly Reviews of Biophysics
- Publisher
- Cambridge University Press (CUP)
- Published
- 2015-09-02
- Volume
- 48
- Issue
- 4
- Pages
- 488-515
- ISSN
- 0033-5835 (ISSN-L)
- 1469-8994
- OpenAlex
- W2402258526
- Cited by
- 367
- References
- 184
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.